In this study, based on the multiple platforms utilized within the Cancer Genome Atlas (TCGA), we performed integrating data from multiple sources including transcriptome, methylome, and clinical outcome to uncover the effect of epigenetic changes acting in the development and progression of EGFR wild type lung cancers with low PD-L1 expression. The gene discussed is EGFR; the disease is lung cancer.